Tony Macintyre
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Tony Macintyre
General Manager, Joint Chief Technical Officer since 2021 / Arovella Therapeutics
Tony Macintyre has over 26 years of experience in various technical and commercial roles.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 10th | Arovella Therapeutics | 432% | 110% |
| 685th | Orion Metals | 0% | 34% |
| 955th | Bentley Capital | -15% | -14% |
| 1708th | Peako | -67% | -20% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 974th |  | Arovella Therapeutics | $1.5m |
| 1173rd | | Real Energy Corporation | $11k |
| 1176th | | Peako | $8k |
| 1183rd | | Bentley Capital | $2k |
| 1186th | | Orion Metals | $1k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: General Manager, Joint Chief Technical Officer since 2021, Arovella Therapeutics | 18 Jan 2021 |
